Clinical Research, Pharma & Healthcare FinancingNewronika Gets FDA IDE for U.S. Trial of Adaptive DBS SystemPR NewswireFebruary 5, 2025February 12, 2025 by PR NewswireFebruary 5, 2025February 12, 2025059 Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption (IDE) from the U.S....
